Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Gossamer Bio Inc
(NQ:
GOSS
)
0.8778
+0.0169 (+1.96%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Gossamer Bio Inc
< Previous
1
2
3
4
5
6
Next >
Benzinga's Top Ratings Upgrades, Downgrades For March 7, 2023
March 07, 2023
Via
Benzinga
Where Gossamer Bio Stands With Analysts
March 01, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2023
March 01, 2023
Via
Benzinga
Barclays Downgrades Gossamer Bio: Here's What You Need To Know
December 07, 2022
Via
Benzinga
What 9 Analyst Ratings Have To Say About Gossamer Bio
December 07, 2022
Via
Benzinga
7 Top Short-Squeeze Candidates to Watch in February
February 01, 2023
For those that want to zig while others zag, these heavily targeted stocks represent the top short-squeeze candidates to watch this month.
Via
InvestorPlace
Looking Into Gossamer Bio's Recent Short Interest
January 03, 2023
Gossamer Bio's (NASDAQ:GOSS) short percent of float has fallen 32.89% since its last report. The company recently reported that it has 14.41 million shares sold short, which is 17.59% of all regular...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
December 22, 2022
Via
Benzinga
Lowe's To Rally Around 19%? Here Are 10 Other Price Target Changes For Thursday
December 08, 2022
Via
Benzinga
ConocoPhillips To Rally Over 30%? Here Are 10 Other Price Target Changes For Wednesday
December 07, 2022
Barclays raised ConocoPhillips (NYSE: COP) price target from $135 to $151. Barclays analyst Jeanine Wai maintained an Overweight rating on the stock. ConocoPhillips shares fell 3.2% to close at $115.61...
Via
Benzinga
What 4 Analyst Ratings Have To Say About Gossamer Bio
November 17, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
December 23, 2022
OnFriday, 143 stocks hit new 52-week lows.
Via
Benzinga
Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session
December 19, 2022
Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial.
Via
Benzinga
Dow Dips Over 500 Points; Nasdaq Down 2.5%
December 06, 2022
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping around 2.5% on Tuesday.
Via
Benzinga
Why Prometheus Biosciences Shares Are Trading Higher By Over 184%? Here Are 55 Stocks Moving In Wednesday's Mid-Day Session
December 07, 2022
Gainers Prometheus Biosciences, Inc. (NASDAQ: RXDX) shares jumped 184.2% to $102.49 after the company announced results for PRA023 in both ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a studies. ARTEMIS-UC...
Via
Benzinga
Analyst Turns Bullish On Aerovate As Competitor Data Reinforce Lead Program Thesis
December 06, 2022
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
December 06, 2022
Via
Benzinga
Why Summit Therapeutics Shares Are Trading Higher By Over 82%? Here Are 53 Stocks Moving In Tuesday's Mid-Day Session
December 06, 2022
Gainers Summit Therapeutics Inc. (NASDAQ: SMMT) shares surged 82.2% to $1.4299 after the company announced a definitive agreement of its partnership with Akeso to in-license its breakthrough bispecific...
Via
Benzinga
Souring Sentiment On Wall Street Sends Dow Down Triple Digits
December 06, 2022
Doubts over the Fed's next move are being compounded with renewed recession anxieties, and this sour sentiment is weighing on markets this afternoon.
Via
Talk Markets
S&P 500 Down Over 1%; Crude Oil Falls Sharply
December 06, 2022
U.S. stocks traded lower midway through trading, with the Dow Jones dropping around 250 points on Tuesday.
Via
Benzinga
President Biden Is Bringing Taiwan Semi (TSM) Stock a HUGE Catalyst
December 06, 2022
Taiwan Semiconductor (TSM) stock is on the move Tuesday as investors prepare for President Joe Biden to visit the company's Arizona plant.
Via
InvestorPlace
Meta Platforms, Herbalife And Some Other Big Stocks Moving Lower On Tuesday
December 06, 2022
U.S. stocks traded lower, with the Dow Jones dropping over 200 points on Tuesday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Why Is Gossamer Bio (GOSS) Stock Down Over 70% Today?
December 06, 2022
GOSS stock is plunging over 70%. The company's hypertension drug reportedly failed to perform better than a competing treatment.
Via
InvestorPlace
Dow Drops 100 Points; US Trade Deficit Widens In October
December 06, 2022
U.S. stocks traded lower this morning, with the Dow Jones dropping around 100 points on Tuesday.
Via
Benzinga
Gossamer Bio Shares Plummet As Hypertension Trial Fall Short Of Expectation
December 06, 2022
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
December 06, 2022
Via
Benzinga
Gossamer Bio Announces Seralutinib Meets Primary Endpoint in Phase 2 TORREY Study in PAH
December 06, 2022
From
Gossamer Bio, Inc.
Via
Business Wire
10 Health Care Stocks Whale Activity In Today's Session
November 30, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
November 18, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Analyst Expects 'Somewhat Smaller Effect Size' From Gossamer Bio's Upcoming PAH Trial
November 17, 2022
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.